ReviewAdvances in therapy2023

Development and Preliminary Validation of an Instrument to Measure Symptoms and Impacts in Patients with Proliferative Diabetic Retinopathy.

Diana Rofail et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.